Effects of sphingosylphosphorylcholine against oxidative stress and acute lung injury induced by pulmonary contusion in rats

dc.authorid0000-0002-2500-7781
dc.contributor.authorAksu, Burhan
dc.contributor.authorAyvaz, Suleyman
dc.contributor.authorAksu, Feyza
dc.contributor.authorKaraca, Turan
dc.contributor.authorCemek, Mustafa
dc.contributor.authorAyaz, Ahmet
dc.contributor.authorDemirtas, Selim
dc.date.accessioned2025-05-10T19:50:24Z
dc.date.issued2015
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBackground/purpose: The goal of this study was to evaluate effects of exogenous sphingosylphosphorylcholine (SPC) administration on acute lung injury induced by pulmonary contusion in rats. Methods: Eight animals were included in each of the following five groups: control, contusion, contusion phosphate-buffered solution (PBS), contusion SPC 2, contusion SPC 10. SPC was administered 3 days at a daily two different doses of 2 mu m/ml and 10 mu m/ml intraperitoneally. The severity of lung injury was determined by the neutrophil activation and histological and immunohistochemical changes in the lung. Malondialdehyde (MDA), nitric oxide (NO), superoxide dismutase (SOD), glutathione peroxidase (GPx) and glutathione (GSH) were determined to evaluate the oxidative status in the lung tissue. Results: Treatment with 2 mu M SPC inhibited the increase in lung MDA and NO levels significantly and also attenuated the depletion of SOD, GPx, and GSH in the lung injury induced by pulmonary contusion. These data were supported by histopathological findings. The inducible nitric oxide synthase (iNOS) positive cells and apoptotic cells in the lung tissue were observed to be reduced with the 2 mu M SPC treatment. But, the 10 mu M SPC treatment did not provide similar effects. Conclusions: In conclusion, these findings suggested that 2 mu M SPC can attenuate lung damage in pulmonary contusion by prevention of oxidative stress, inflammatory process and apoptosis. All these findings suggest that low dose SPC may be a promising new therapeutic agent for acute lung injury. (C) 2015 Published by Elsevier Inc.
dc.identifier.doi10.1016/j.jpedsurg.2014.06.007
dc.identifier.endpage597
dc.identifier.issn0022-3468
dc.identifier.issn1531-5037
dc.identifier.issue4
dc.identifier.pmid25840069
dc.identifier.scopus2-s2.0-84964241062
dc.identifier.scopusqualityQ1
dc.identifier.startpage591
dc.identifier.urihttps://doi.org/10.1016/j.jpedsurg.2014.06.007
dc.identifier.urihttps://hdl.handle.net/20.500.14730/12353
dc.identifier.volume50
dc.identifier.wosWOS:000352140500019
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherW B Saunders Co-Elsevier Inc
dc.relation.ispartofJournal of Pediatric Surgery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectSPC
dc.subjectAcute lung injury
dc.subjectPulmonary contusion
dc.subjectOxidative stress
dc.subjectLipid peroxidation
dc.subjectNitric oxide
dc.titleEffects of sphingosylphosphorylcholine against oxidative stress and acute lung injury induced by pulmonary contusion in rats
dc.typeArticle

Dosyalar